Top Links

Articles Related to gestation

The Efficiency and Safety of a Resveratrol and Alpha Lipoic Acid Combination in the Prevention of Gestational Diabetes Related Complications: A Retrospective Clinical Trial

Gestational diabetes mellitus (GDM) is associated with an increased maternal and fetal risk of complications. Other than lifestyle modifications and diet, little prevention can be done towards this maternal complication. Through a preclinical approach and a retrospective clinical trial, we investigated the effects of maternal supplementation with a nutraceutical composition based on resveratrol (RSV) and alpha-lipoic acid (ALA) on insulin resistance and GDM status
View complete article: PDF  |  Full-text

Thrombocytopenia in Women Initiating Antenatal Care in Port Harcourt

Thrombocytopenia is a reduction in the platelet count below the reference range of 150 x 109 /L. It is the second commonest hematologic disorder, following anaemia in pregnancy. Women with thrombocytopenia in pregnancy have a higher tendency to bleed; postpartum haemorrhage is a major cause of maternal mortality in our setting.
View complete article: PDF  |  Full-text

Labetalol in Comparison to Methyl Dopa in Treatment of Gestational Hypertension, A Randomized Trial

To evaluate the value and safety of labetalol in comparison to Alfa methyldopa in treatment of pregnant women with pregnancy-induced hypertension (PIH). 264 patients with PIH were randomly distributed to take either methyldopa (group 1) labetalol (group 2). or Intake of medications with respect to Age, gravidity, Blood Pressure measurement, albumin in urine measurement Levels, Side Effects, dose of the drug, increasing duration of pregnancy, mode of delivery, Perinatal safety and APGAR scores were studied. The statistical level of significance was taken at P<0.05.
View complete article: PDF  |  Full-text

Macrocystis of the Lung in a Preterm Neonate: Case Report

Thoracic ultrasonography has been used to evaluate pulmonary parenchyma and the macrocystis of the lung in a preterm with congenital cystic adenomatoid malformation type I. The images gained have been important for diagnosis and therapeutic strategies in our case. An infant was prematurely born with congenital cystic adenomatoid malformation type I. The chest X-ray and computerized tomography showed a great opaque area in the entire right lung, we considered performing a pneumonectomy. This opaque area hampered the expansion of left lung. After draining the macrocystis by ultrasonography-guided puncture, it was possible considering and performing the lobectomy due to the reduction of the volume of macrocystis. During follow up at 4 months, the infant did not show complications and the chest X-ray revealed the reduction of volume of the dense area in parenchyma of right lung.
View complete article: PDF  |  Full-text

Utility of Serum Bilirubin Screening during the First 24-Hours Following Birth of Pre-Term Neonates <35 Weeks’ Gestation

Neonates with severe hyperbilirubinaemia are at increased risk for neurological morbidity. Risk factors for early onset hyperbilirubinaemia include prematurity, red cell haemolysis and birth trauma. As most neonates are asymptomatic and clinical evaluation in detecting early jaundice limited, clinical practice guidelines at the Royal Women’s Hospital recommend a serum bilirubin (SBR) level in the first 24 hours following birth for neonates <35 weeks’ gestation. Our audit aims to describe the utility of SBR screening in this population
View complete article: PDF  |  Full-text

Case Report of Severe Preeclampsia and Associated Postpartum Complications

Preeclampsia is clinically defined by hypertension and proteinuria, with or without pathologic edema that occurs after 20 weeks’ gestation, but can also present up to 4-6 weeks post-partum. Worldwide, incidence of preeclampsia is 5-14 percent of all pregnancies, while severe preeclampsia can develop to about 25 percent of all cases of preeclampsia.
View complete article: PDF  |  Full-text

A Rare Coexistence: Omphalomesenteric Remnant with Appendix and Caecum Duplication

The nutrition source of developing embryo at early stages is the omphalomesenteric duct which obliterates latter. Failure of this obliteration process brings on omphalomesenteric remnants.
View complete article: PDF  |  Full-text

Inflammatory Myofibroblastic Tumor of Proximal Urethra in a Pregnant Female: A Unique Case Report

Inflammatory Myofibroblastic tumour (IMT) is a rare spindle tumour that mimics malignant processes. It can affect any part of the body, but rarely occurs in the genitourinary tract. We report a case of urethral IMT in a 31-year-old pregnant female of 18 weeks gestational age.
View complete article: PDF  |  Full-text

Effects of Oxytocin and Carbetocin on Haemostatic Variables in Pregnant Women after Cesarean Section

Uterine atony is the first cause of haemorrhage at delivery. To prevent post partum major bleeding uterotonic prophylactic drugs are commonly used after caesarean section. Few studies showed an haemostatic activation after oxytocin infusion while no data are available on carbetocin.
View complete article: PDF  |  Full-text

Descriptive Study of Exposure to Inhalation Zanamivir and Pregnancy-Related Outcomes

The Health Improvement Network (THIN) provided data from UK General Practitioners (GPs) for 144 pregnant women who were prescribed zanamivir and 144 age- and date-matched untreated comparators with no recorded diagnosis of influenza. Groups were assessed for baseline characteristics, treatment-emergent diagnoses in the mother, pregnancy outcomes and congenital malformations diagnosed in the offspring within 28 days of birth.
View complete article: PDF  |  Full-text

Pharmacy Compounding Quality Control and Pharmaceutical Development Strategies for Seventeen alpha Hydroxyprogesterone Caproate in Prevention of Preterm Delivery

Seventeen alpha hydroxyprogesterone caproate (17-OHPC) is the only FDA-approved drug labeled for prevention of preterm delivery. This drug is also available as a compounded product from licensed compounding pharmacies. This article reviews the FDA approval history and pharmacy compounding quality control data of 17-OHPC, as well as briefly discusses possible future pharmaceutical development strategies for 17-OHPC.
View complete article: PDF  |  Full-text

Unusual Presentation of CML in Pregnancy

Leukemia during pregnancy is rare, posing a complex series of questions, including appropriate therapy and maternalcounseling. Management of chronic myelocytic leukemia (CML) during pregnancy is limited.
View complete article: PDF  |  Full-text


Editorial Board Members Related to gestation

Shirley Mcilvenny

Professor
Department of Health and Nutrition
National Institute of Integrative Medicine
Australia

Ahmed Ragab Gaber Ahmed

Faculty of Science
Beni-Suef University
Egypt

WANG CHI CHIU

Professor
Department of Obstetrics & Gynecology
The Chinese University of Hong Kong
Hong Kong
Submit Manuscript